These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 26394134)

  • 1. Sacral Neuromodulation for Genitourinary Problems.
    Banakhar M; Hassouna M
    Prog Neurol Surg; 2015; 29():192-9. PubMed ID: 26394134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacral neuromodulation for lower urinary tract dysfunction.
    Van Kerrebroeck PE; Marcelissen TA
    World J Urol; 2012 Aug; 30(4):445-50. PubMed ID: 21989816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacral Neuromodulation: Standardized Electrode Placement Technique.
    Matzel KE; Chartier-Kastler E; Knowles CH; Lehur PA; Muñoz-Duyos A; Ratto C; Rydningen MB; Sørensen M; van Kerrebroeck P; de Wachter S
    Neuromodulation; 2017 Dec; 20(8):816-824. PubMed ID: 28975677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of Sacral Nerve Stimulation Devices for Magnetic Resonance Imaging: What Happens Next?
    Lloyd JC; Gill BC; Pizarro-Berdichevsky J; Goldman HB
    Neuromodulation; 2017 Dec; 20(8):836-840. PubMed ID: 29024404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensing in Sacral Neuromodulation: A Feasibility Study in Subjects With Urinary Incontinence and Retention.
    Goudelocke C; Jungbauer Nikolas LM; Bittner KC; Offutt SJ; Miller AE; Slopsema JP
    Neuromodulation; 2024 Feb; 27(2):392-398. PubMed ID: 37589643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis.
    Rensing AJ; Szymanski KM; Dunn S; King S; Cain MP; Whittam BM
    J Pediatr Urol; 2019 Feb; 15(1):39.e1-39.e6. PubMed ID: 30473473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms.
    Van Kerrebroeck PE
    Int Urogynecol J; 2010 Dec; 21 Suppl 2(Suppl 2):S467-74. PubMed ID: 20972546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention.
    Denzinger S; Nowrotek A; Weingart P; Burger M; Wieland WF; Rößler W; Otto W
    Neuromodulation; 2012; 15(6):586-91; discussion 591. PubMed ID: 22672285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacral nerve stimulation for neuromodulation of the lower urinary tract.
    Hubsher CP; Jansen R; Riggs DR; Jackson BJ; Zaslau S
    Can J Urol; 2012 Oct; 19(5):6480-4. PubMed ID: 23040633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the axonics modulation technologies sacral neuromodulation system for the treatment of urinary and fecal dysfunction.
    Cohn JA; Kowalik CG; Kaufman MR; Reynolds WS; Milam DF; Dmochowski RR
    Expert Rev Med Devices; 2017 Jan; 14(1):3-14. PubMed ID: 27915486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study.
    Chaabane W; Guillotreau J; Castel-Lacanal E; Abu-Anz S; De Boissezon X; Malavaud B; Marque P; Sarramon JP; Rischmann P; Game X
    Neurourol Urodyn; 2011 Apr; 30(4):547-50. PubMed ID: 21488095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Invasive neurostimulation in neuro-urology: state of the art].
    Kurze I; Böthig R; van Ophoven A
    Aktuelle Urol; 2024 Aug; 55(4):351-364. PubMed ID: 38631373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.
    Tahseen S
    Int Urogynecol J; 2018 Aug; 29(8):1081-1091. PubMed ID: 29302716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Appropriate Prolonged Sacral Neuromodulation Testing in Improving Implantation Rate of a Permanent Implantable Pulse Generator in Patients with Refractory Lower Urinary Tract Dysfunctions in Mainland China.
    Zhang P; Zhang JZ; Wu LY; Zhang XD
    Chin Med J (Engl); 2017 Feb; 130(4):439-444. PubMed ID: 28218218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary analysis of stimulation parameters for sacral neuromodulation in different indications: a multicenter retrospective cohort study from China.
    Meng L; Yan Z; Wang X; Zhang Y; Zhu Z; Zhu W; Ling Q; Sun X; Gu Y; Lv J; Li Y
    Int J Surg; 2024 Jun; 110(6):3536-3542. PubMed ID: 38445489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral nerve stimulation for the treatment of refractory voiding and bowel dysfunction.
    Noblett KL; Cadish LA
    Am J Obstet Gynecol; 2014 Feb; 210(2):99-106. PubMed ID: 23899452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre.
    Gajewski JB; Al-Zahrani AA
    BJU Int; 2011 Apr; 107(8):1258-64. PubMed ID: 20883483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SACRAL NEUROMODULATION IN TREATING OVERACTIVE BLADDER PATIENTS - FIRST-TIME APPLICATION IN CROATIA.
    Bakula M; Hauptman D; Hudolin T; Škegro SN; Tudor KI; Bakula B; Kaštelan Ž
    Acta Clin Croat; 2023 Jul; 62(Suppl2):143-147. PubMed ID: 38966014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.